This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Staying motivated is key to achieving your financial goals. Explore various strategies to inspire yourself and maintain focus on your objectives.
12,387 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
When oil prices spike, the market story often shifts. This piece uses prices skyrocketing years history to explore wh...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Intel stock popped today as optimism about AI demand and data-center upgrades fed investor enthusiasm. This article b...
Investors have watched Micron stock keep going lower despite upbeat earnings. This deep dive explains the forces behi...
Oil markets jump as Iran keeps Strait Hormuz under pressure, signaling potential disruption to energy flows. Investor...
Meta Platforms unveils a multi-year AI infrastructure push totaling up to $145 billion, reshaping supplier valuations...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...